U.S. markets closed

Concert: 3Q Earnings Snapshot

LEXINGTON, Mass. (AP) _ Concert Pharmaceuticals Inc. (CNCE) on Thursday reported a third-quarter loss of $17.4 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Lexington, Massachusetts-based company said it had a loss of 74 cents.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 62 cents per share.

The biopharmaceutical company posted revenue of $11,000 in the period.

Concert shares have dropped 42 percent since the beginning of the year. The stock has decreased 12 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CNCE at https://www.zacks.com/ap/CNCE